This Group focuses on expanding what we know about the genetic, epigenetic and immunologic backgrounds of gastrointestinal tumour diseases. Clinical trials focus on preclinical to clinical interaction and integrating early drug development, ensuring that new aspects of tumour biology are investigated with appropriate technology.


Want to read in detail our scientific findings on specific tumour type?
Search through our comprehensive list of EORTC published articles to date.